Chest CT Using Low-concentration Iodine Contrast Media

ConditionPulmonary Disease

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age19+

SponsorJung Im Jung

About this trial

This study aims to evaluate the quality of images when low-concentration iodine contrast agents is used in chest CT with low tube voltage and if they can be used in routine imaging.

The primary endpoint of the study was the quality of the image and comparison of chest CT by using low and conventional concentration iodine contrast agents with low tube voltage and chest CT by using the conventional concentration iodine contrast agents with the conventional tube voltage; The secondary endpoint is optimizing chest CT protocol using an iodine contrast agent.

Eligibility criteria

Qualifiers

Patients aged 19 years or older, weighing less than 90 kg, and BMI less than 30 who underwent contrast-enhanced chest CT alone

Disqualifiers

Under the age of 18

Cases where contrast-enhanced CT cannot be performed

Heart failure

Pregnancy

Trial design

Treatments tested in this trial

Iohexol (320mgI/mL) with 120kVp
Iohexol (320mgI/mL) with 100kVp
Iohexol (270mgI/mL) with 100kVp
Iohexol (240mgI/mL) with 100kVp

Treatment groups

370 Participants

are divided into 4 treatment groups

Sponsors and collaborators

Jung Im Jung

Lead sponsor

Seoul St. Mary's Hospital

Sponsor institution

Taejoon Pharmaceutical Co., Ltd.

Collaborator

Source ClinicalTrials.gov